The effect of travoprost on daytime intraocular pressure in normal tension glaucoma: A randomised controlled trial

British Journal of Ophthalmology

Volumn 92, Issue 8, 2008, Pages 1129-1133

  Ang, G S ^a   Kersey, J P ^a   Shepstone, L ^b   Broadway, D C ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRAVOPROST;

AGED; ALLERGIC CONJUNCTIVITIS; ARTICLE; BEDTIME DOSAGE; CIRCADIAN RHYTHM; CONTROL GROUP; CONTROLLED STUDY; DRY EYE; EYE COLOR; FEMALE; FOLLOW UP; GLAUCOMA; HEADACHE; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTIHYPERTENSIVE AGENTS; CIRCADIAN RHYTHM; CLOPROSTENOL; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 49049111592     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.135269     Document Type: Article

References (23)

1. Goldberg I. Relationship between intraocular pressure and preservation of visual field in glaucoma. Surv Ophthalmol 2003;48(Suppl 1):3-S7S.
2. The Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998;126:498-505.
3. The Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998;126:487-97.
4. Hoyng PFJ, Kitazawa Y. Medical treatment of normal tension glaucoma. Surv Ophthalmol 2002;47(Suppl 1):116-24S.
5. McKibbin M, Menage MJ. The effect of once-daily latanoprost on intraocular pressure and pulsatile ocular blood flow in normal tension glaucoma. Eye 1999;13:31-4.
6. Greve EL, Rulo AH, Drance SM, et al. Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: a review of short-term studies with three dose regimens of latanoprost treatment. Surv Ophthalmol 1997:41(Suppl 2):89-92S.
7. Rulo AH, Greve EL, Geijssen HC, et al. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma. Ophthalmology 1996;103:1276-82.
8. Tamada Y, Taniguchi T, Murase H, et al. Intraocular-pressure lowering efficacy of latanoprost in patients with normal-tension glaucoma or primary open-angle glaucoma. J Ocul Pharmacol Ther 2001;17:19-25.
9. Ang A, Reddy MA, Shepstone L, et al. Long term effect of latanoprost on intraocular pressure in normal tension glaucoma. Br J Ophthalmol 2004;88:630-4.
10. Oh JY, Park KH. The effect of latanoprost on intraocular pressure during 12 months of treatment for normal-tension glaucoma. Korean J Ophthalmol 2005;19:297-301.
11. Ishibashi S, Hirose N, Tawara A, et al. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma. J Glaucoma 2006;15:354-7.
12. Dirks MS, Noecker RJ, Earl M, et al. A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma. Adv Ther 2006;23:385-94.
13. Zeitz O, Matthiessen ET, Reuss J, et al. Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide. BMC Ophthalmol 2005;5:6.
14. Chen MJ, Cheng CY, Chen YC, et al. Effects of bimatoprost 0.03% on ocular hemodynamics in normal tension glaucoma. J Ocul Pharmacol Ther 2006;22:188-93.
15. Li N, Chen X, Zhou Y, et al. Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials. Clin Exp Ophthalmol 2006;34:755-64.
16. Asrani S, Zeimer R, Wilensky J, et al. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000;9:134-42.
17. Jonas JB, Budde WM, Stroux A, et al. Diurnal intraocular pressure profiles and progression of chronic open-angle glaucoma. Eye 2007;21:948-51.
18. Orzalesi N, Rossetti L, Bottoli A, et al. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Ophthalmology 2006;113:239-46.
19. Konstas AG, Kozobolis VP, Katsimpris IE, et al. Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients. Ophthalmology 2007;114:653-7.
20. Konstas AG, Mikropoulous D, Kaltsos K, et al. 24-hour intraocular pressure control obtained with evening-versus morning-dosed travoprost in primary open-angle glaucoma. Ophthalmology 2006;113:446-50.
21. Parrish RK, Palmberg P, Sheu WP, et al. A comparison of latanoprost, bimatoprost and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol 2003;135:688-703.
22. Hepsen IF, Ozkaya E. 24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension. Eye 2007;21:453-8.
23. Yildirim N, Sahin A, Gultekin S. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma. J Glaucoma 2008;17:36-9.